Status:
COMPLETED
Malaria Surveillance in Rakai, Uganda
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Malaria
Eligibility:
All Genders
6-99 years
Brief Summary
Background: \- Malaria is a leading cause of morbidity and mortality in Uganda, accounting for more than a quarter of all outpatient visits at health facilities, 20 percent of hospital admissions, an...
Detailed Description
Malaria is a leading cause of morbidity and mortality in Uganda, accounting for 25-40 percent of all outpatient visits at health facilities, 20 percent of hospital admissions, and 9-14 percent of inpa...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Child aged 6 months to less than 10 years, primary care giver of an enrolled child, or an adolescent/adult resident in a household of an enrolled child.
- Willingness to participate in the study as evidenced by a completed and signed parental informed consent document and consent for child research participation (with assent of child/adolescent if appropriate).
- EXCLUSION CRITERIA:
- Clinical evidence of an acute, life-threatening illness requiring immediate medical care at time of baseline household visit, not including severe malaria.
- Intent to stay in a study household for less than 12 months from the start of the study.
- School-going child in a boarding school who spends most of their time in a year at school rather than at home.
Exclusion
Key Trial Info
Start Date :
December 22 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 23 2013
Estimated Enrollment :
1650 Patients enrolled
Trial Details
Trial ID
NCT01265407
Start Date
December 22 2010
End Date
July 23 2013
Last Update
October 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rakai Health Sciences Program
Rakai, Uganda